Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: A 10‐years us perspective

@article{Singh2015InfluenceOH,
  title={Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: A 10‐years us perspective},
  author={Vikas Singh and Apurva Omkar Badheka and Nileshkumar J Patel and Ankit Chothani and Kathan D Mehta and Shilpkumar Arora and Nilay Patel and Abhishek J. Deshmukh and Neeraj Shah and Ghanshyambhai T. Savani and Ankit D Rathod and Sohilkumar Manvar and Badal Thakkar and Vinaykumar Panchal and Jay Patel and Igor F. Palacios and Charanjit S. Rihal and Mauricio G. Cohen and William W. O’Neill and Eduardo de Marchena},
  journal={Catheterization and Cardiovascular Interventions},
  year={2015},
  volume={85}
}
Background: Contemporary data regarding percutaneous closure of atrial septal defect/patent foramen ovale (ASD/PFO) are lacking. We evaluated the current trends in utilization of ASD/PFO closure in adults and investigated the effect of annual hospital volume on in‐hospital outcomes. Methods: We queried the Nationwide Inpatient Sample between the years 2001 and 2010 using the International Classification of Diseases (ICD‐9‐CM) procedure code for percutaneous closure of ASD/PFO with device… 

Impact of hospital volume on outcomes of percutaneous ASD/PFO closure in pediatric patients

Increasing annual hospital volume is an independent predictor of lower complication rates in percutaneous ASD closure cases with no associated mortality in pediatric patients.

Incidence and Causes of 30-day Readmissions after Surgical Versus Percutaneous Secundum Atrial Septal Defect Closure: A United States Nationwide Analysis

Percutaneous ASD closure is associated with lower rates of 30-day readmissions, mean length of hospital stay, and hospital charges as compared with surgical closure.

Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale

About 1 in 14 patients who underwent percutaneous transcatheter PFO closure after ischemic stroke or TIA experienced a serious periprocedural adverse outcome or death, and the risk of adverse outcomes was highest in older patients and in those with preceding isChemic stroke.

Intracardiac echocardiography guidance for percutaneous transcatheter closure of atrial septal defects: A nationwide registry data analysis

Percutaneous transcatheter ASD closure under ICE guidance was as feasible as those under TEE guidance, and currently, ICE guidance seems to be used for less challenging cases in high-volume centers.

Percutaneous atrial septal defect closure: a consensus document of the joint group of experts from the Association of Cardiovascular Interventions and the Grown-Up Congenital Heart Disease Section of the Polish Cardiac Society.

The joint group of experts from the Association of Cardiovascular Interventions and the Grown‑Up Congenital Heart Disease Section of the Polish Cardiac Society developed the following consensus opinion in order to standardize the principles of diagnosis, indications for treatment, methods of performing procedures, and tenets of postoperative care in Poland.

Percutaneous closure of atrial septal defect A consensus document of the joint group of experts from the Association of Cardiovascular Interventions and the Grown ‑Up Congenital Heart Disease Section of the Polish Cardiac Society

The joint group of experts from the Association of Cardiovascular Interventions and the Grown ‑Up Congenital Heart Disease Section of the Polish Cardiac Society developed the following consensus opinion in order to standardize the principles of diagnosis, indications for treatment, methods of performing procedures, and tenets of postoperative care in Poland.

Interventional closure of patent foramen ovale in prevention of thromboembolic events. Consensus document of the Association of Cardiovascular Interventions and the Section of Grown-up Congenital Heart Disease of the Polish Cardiac Society.

The joint expert group of the Association of Cardiovascular Interventions and the Grown-Up Congenital Heart Disease Section of the Polish Cardiac Society developed the following consensus opinion in order to standardize the principles of diagnosis, indications, methods of performing procedures and post-operative care in relation to Polish conditions and experiences.

Influence of hospital volume and outcomes of adult structural heart procedures.

An overview of the available literature underscores the importance of hospital volume in complex structural heart disease interventions, both in lower mortality and complications as well as better economics in terms of lower length of stay and hospitalization costs seen at high volume centers.

References

SHOWING 1-10 OF 32 REFERENCES

Percutaneous treatment of patent foramen ovale and atrial septal defects.

Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004.

It is unlikely that sickness and perception explain the observed association because the data used to classify patients’ exposure to chronic job strain were collected before patients knew about their relevant recurrent coronary heart disease event.

Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.

There was no significant benefit associated with closure of a patent foramen ovale in adults who had had a cryptogenic ischemic stroke, however, closure was superior to medical therapy alone in the prespecified per-protocol and as-treated analyses, with a low rate of associated risks.

Comparison of contemporary devices used for transcatheter patent foramen ovale closure.

Device design does not seem to impact the success of the PFO closure procedure, and AF was the only predictor of recurrent TEs, underscoring the importance of aggressive therapy for atrial arrhythmias early following PFOclosure.

Transcatheter Closure of Patent Foramen Ovale in Patients with Platypnea-Orthodeoxia: Results of a Multicentric French Registry

Percutaneous occlusion of the foramen ovale is safe and gives excellent results thanks to continuing improvement in available devices, and enables some patients in an unstable condition to avoid a surgical closure.

Closure or medical therapy for cryptogenic stroke with patent foramen ovale.

In patients with cryptogenic stroke or TIA who had a patent foramen ovale, closure with a device did not offer a greater benefit than medical therapy alone for the prevention of recurrent stroke orTIA.